@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

<https://kip.rkkp.dk/fhir/ValueSet/ATCImmunotherapyCLL> a fhir:ValueSet ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "ATCImmunotherapyCLL"] ; # 
  fhir:text [
     fhir:status [ fhir:v "extensions" ] ;
     fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet ATCImmunotherapyCLL</b></p><a name=\"ATCImmunotherapyCLL\"> </a><a name=\"hcATCImmunotherapyCLL\"> </a><a name=\"ATCImmunotherapyCLL-en-US\"> </a><p>This value set includes codes based on the following rules:</p><ul><li>Include these codes as defined in <a href=\"CodeSystem-GenericValues.html\"><code>https://kip.rkkp.dk/fhir/CodeSystem/GenericValues</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href=\"CodeSystem-GenericValues.html#GenericValues-none\">none</a></td><td>Ingen immunterapi</td><td>None - used to choose none of the available values</td></tr><tr><td><a href=\"CodeSystem-GenericValues.html#GenericValues-other\">other</a></td><td>Andet</td><td>Other - used to choose unspecific value not in a valueset</td></tr></table></li><li>Include these codes as defined in <a href=\"CodeSystem-ATC.html\"><code>https://kip.rkkp.dk/fhir/CodeSystem/ATC</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L04AA34\">L04AA34</a></td><td>Alemtuzumab</td><td>L04AA34 - alemtuzumab</td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L01FA01\">L01FA01</a></td><td>Rituximab</td><td>L01FA01 - rituximab</td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L01FA02\">L01FA02</a></td><td>Ofatumumab</td><td>L01FA02 - ofatumumab</td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L01FA03\">L01FA03</a></td><td>Obinutuzumab</td><td>L01FA03 - obinutuzumab</td></tr></table></li></ul></div>"^^rdf:XMLLiteral
  ] ; # 
  fhir:url [ fhir:v "https://kip.rkkp.dk/fhir/ValueSet/ATCImmunotherapyCLL"^^xsd:anyURI] ; # 
  fhir:version [ fhir:v "2.11.1"] ; # 
  fhir:name [ fhir:v "ATCImmunotherapyCLL"] ; # 
  fhir:title [ fhir:v "ATC_CLL_immunterapi"] ; # 
  fhir:status [ fhir:v "active"] ; # 
  fhir:experimental [ fhir:v true] ; # 
  fhir:date [ fhir:v "2022-07-13T00:00:00+02:00"^^xsd:dateTime] ; # 
  fhir:publisher [ fhir:v "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S"] ; # 
  fhir:contact ( [
     fhir:name [ fhir:v "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S" ] ;
     fhir:telecom ( [
       fhir:system [ fhir:v "url" ] ;
       fhir:value [ fhir:v "https://trifork.com" ]
     ] [
       fhir:system [ fhir:v "email" ] ;
       fhir:value [ fhir:v "rbk@trifork.com" ]
     ] )
  ] ) ; # 
  fhir:description [ fhir:v "ATC koder immunterapi - [CLL]"] ; # 
  fhir:compose [
     fhir:include ( [
       fhir:system [ fhir:v "https://kip.rkkp.dk/fhir/CodeSystem/GenericValues"^^xsd:anyURI ] ;
       fhir:concept ( [
         fhir:code [ fhir:v "none" ] ;
         fhir:display [ fhir:v "Ingen immunterapi" ]
       ] [
         fhir:code [ fhir:v "other" ] ;
         fhir:display [ fhir:v "Andet" ]
       ] )
     ] [
       fhir:system [ fhir:v "https://kip.rkkp.dk/fhir/CodeSystem/ATC"^^xsd:anyURI ] ;
       fhir:concept ( [
         fhir:code [ fhir:v "L04AA34" ] ;
         fhir:display [ fhir:v "Alemtuzumab" ]
       ] [
         fhir:code [ fhir:v "L01FA01" ] ;
         fhir:display [ fhir:v "Rituximab" ]
       ] [
         fhir:code [ fhir:v "L01FA02" ] ;
         fhir:display [ fhir:v "Ofatumumab" ]
       ] [
         fhir:code [ fhir:v "L01FA03" ] ;
         fhir:display [ fhir:v "Obinutuzumab" ]
       ] )
     ] )
  ] . # 

# -------------------------------------------------------------------------------------

